<?xml version="1.0" encoding="UTF-8"?>
<p>Second, 
 <italic>the discontinuation of smoking</italic>. Whilst smoking remains one of the most important preventable risk factors for premature death, recent evidence suggests a lack of association between smoking and adverse COVID-19 outcome [
 <xref rid="B10" ref-type="bibr">10</xref>]. This could partly be explained by high case-fatality among elderly patients with multiple comorbidities tending to be non- or former smokers due health reasons. Nonetheless, smoking results in comorbidities that have been associated with poor COVID-19 outcomes, including cardiac events. Furthermore, smoking is known to be associated with viral infections and severity (e.g., influenza) as smokers are more likely to have poorer lung function/capacity [
 <xref rid="B11" ref-type="bibr">11</xref>], contract microbial diseases (through structural changes in the respiratory tract, decreased immunity) [
 <xref rid="B12" ref-type="bibr">12</xref>], and perform repetitive hand-to-mouth movements. Considering this, recommendations advocate for an immediate cessation of smoking habits to prevent detrimental COVID-19 consequences.
</p>
